References
- 1
Bialer PA.
Designer drugs in the general hospital.
Psychiatr Clin North Am.
2002;
25
231-243
- 2
Dyer JE, Roth B, Hyma BA.
Gamma-hydroxybutyrate withdrawal syndrome.
Ann Emerg Med.
2001;
37
147-53
- 3
Herold AH, Sneed KB.
Treatment of a young adult taking gamma-butyrolactone (GBL) in a primary care clinic.
J Am Board Fam Pract.
2002;
15
161-163
- 4
Hohl-Radke F, Voß M, Staedt J.
Severe delirium of uncertain origin in a German psychiatric unit – caused by gamma-butyrolactone
withdrawal.
Pharmacopsychiatry.
2008;
41
200-201
- 5
Kam PC, Yoong FF.
Gamma-hydroxybutyric acid: an emerging recreational drug.
Anaesthesia.
1998;
53
1195-1198
- 6
McDaniel CH, Miotto KA.
Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
J Psychoactive Drugs.
2001;
33
143-149
- 7
McDonough M, Kennedy N, Glasper A. et al .
Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
Drug Alcohol Depend.
2004;
75
3-9
- 8 Miotto K, Roth B.
GHB withdrawal syndrome. Texas Commission on Alcohol and Drug Abuse (TCADA) March 2001
- 9
Nimmerrichter AA, Walter H, Gutierrez-Lobos KE. et al .
Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment
of alcohol withdrawal.
Alcohol Alcohol.
2002;
37
67-73
- 10
Rosenberg MH, Deerfield LJ, Baruch EM.
Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit:
recommendations for management.
Am J Drug Alcohol Abuse.
2003;
29
487-496
- 11
Schneir AB, Ly BT, Clark RF.
A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol.
J Emerg Med.
2001;
21
31-33
- 12
Tarabar AF, Nelson LS.
The gamma-hydroxybutyrate withdrawal syndrome.
Toxicol Rev.
2004;
23
45-49
- 13
Wojtowicz JM, Yarema MC, Wax PM.
Withdrawal from gamma-hydroxybutyrate,1,4-butanediol and gamma-butyrolactone: a case
report and systematic review.
Can J Emergency Med.
2008;
10
69-74
- 14
Zepf FD, Holtmann M, Duketis E. et al .
Entzugsdelir nach Missbrauch von GHB-(Gamma-Hydroxybutyrat) und seiner Vorstufen –
Grundlagen und Bedeutung für die Kinder- und Jugendpsychiatrie. Zeitschrift für Kinder-
und Jugendpsychiatrie und Psychotherapie.
.
2009;
37(5)
413-420
Correspondence
Prof. Dr. med. F. D. Zepf
Juniorprofessor for Translational Neuroscience in Psychiatry and Neurology
Department of Child and Adolescent Psychiatry and Psychotherapy
RWTH Aachen University
Neuenhofer Weg 21
52074 Aachen
Germany
Phone: +49/241/8085 504
Fax: +49/241/8082 544
Email: fzepf@ukaachen.de
